Source Report 11

Oklo and NuScale Valuations and Radiant Test Status (2026)

Full research prompt

What are the current market caps, enterprise values and price-to-book multiples of Oklo and NuScale, and did Radiant complete its summer 2026 INL DOME test?

From Company Analysis: Nano Nuclear Energy (NNE) — Micro Reactors for the AI Data Center Era

Jon Sinclair using Luminix AI
Jon Sinclair using Luminix AI Strategic Research
Key Takeaway from Company Analysis: Nano Nuclear Energy (NNE) — Micro React...

Nano Nuclear Energy trades at a $1.1 billion market cap as a pre-revenue, pre-prototype microreactor developer targeting AI data centers. The company focuses on advanced nuclear solutions for high-energy demands in the AI era. Its valuation reflects strong market anticipation despite lacking prototypes or sales.

Oklo (NYSE: OKLO) market cap is approximately $4.67 billion as of mid-November 2026 (stock price ~$23–24), with enterprise value in the $2.1–3.6 billion range and price-to-book around 1.28.[1][2][3]

Multiple financial data platforms (e.g., StockAnalysis, YCharts, GuruFocus) report consistent market cap figures near $4.67 billion on or around November 13–16, 2026, based on ~195 million shares outstanding and recent trading levels. Enterprise value calculations vary due to Oklo’s substantial cash position from equity raises (often exceeding $2–3 billion in cash/marketable securities), which can produce lower or even negative EV in some methodologies; reported figures cluster in the low-to-mid $2 billion range or slightly higher.[2][4][3] Price-to-book has declined sharply with the stock’s pullback from 2025 highs, landing at ~1.28–1.30 in recent daily/quarterly data (down from multi-digit levels earlier).[5][2][6]

NuScale Power (NYSE: SMR) market cap is approximately $1.9–2.0 billion as of mid-November 2026 (stock price ~$4.5–4.7), with enterprise value around $1.0–1.4 billion and price-to-book near 0.95.[7][8]

Data aggregators show market cap in the $1.85–2.0 billion band on recent closes (e.g., ~$1.91–2.00 billion around November 13), with ~410–430 million shares outstanding and a stock price in the mid-$4 range after significant 2026 declines. Enterprise value sits lower due to cash holdings, with figures commonly reported between ~$840 million and $1.4 billion.[8][9][10] Price-to-book is sub-1.0x at ~0.95 in the latest statistics, reflecting the stock’s performance and balance sheet.[8][11]

Radiant Nuclear did not complete its planned summer 2026 (or Q3 2026 full-power) INL DOME test campaign.[12][13]

Radiant shipped its Kaleidos 1 MWe microreactor to Idaho National Laboratory’s DOME facility in August 2026 and received TRISO fuel shipments earlier that summer, with original targets for initial startup/criticality in summer 2026 and a multi-phase campaign culminating in ≥150 hours of continuous full-power operation (targeted for Q3 2026).[14][15] As of late October 2026, the U.S. Department of Energy approved the reactor’s Documented Safety Analysis (DSA) for full-power operations—the key regulatory step enabling the test campaign—but the next required step (DOE Readiness Review) remained pending. This review is a prerequisite for fuel loading and nuclear operations.[12][16]

An INL update around September 30, 2026, referenced Radiant having “completed the first DOME test,” but contemporaneous and later reporting indicates this did not encompass fueled criticality, power operation, or the full-power demonstration; the reactor had not yet been fueled or started nuclear operations by early November 2026.[13][17] The full summer/Q3 2026 powered test objectives were therefore not achieved, with the program still in the pre-operational phase as of the most recent available information.

Notes on data currency and interpretation: All market figures reflect trading activity and valuations as of November 13–16, 2026 (or the most recent closes reported in sources). Enterprise value and multiples can shift with cash balances, share issuances, and market movements; Oklo in particular has seen large equity raises that materially affect EV. Price-to-book uses the most recent reported ratios from valuation platforms. Radiant test status is based on October–November 2026 public announcements and reporting; no later confirmation of test completion appears in the results.

Sources

For Informational Purposes Only

This AI-generated research is for informational and educational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Luminix is not a registered investment advisor. Always consult a qualified financial advisor before making investment decisions. Data may contain inaccuracies — verify independently before acting.

Get Custom Research Like This

Start Your Research